Previous studies confirm that vaspin can improve glucose metabolism and insulin sensitivity in obesity, attenuate adipose tissue inflammation, taken together, partially ameliorate the adverse effects of DIO. This evidence concerns the gene SERPINA12 and obesity due to melanocortin 4 receptor deficiency.